Non-profit · founded 1993

The Geneva Foundation

Tacoma, United States · genevausa.org

Manage this page

Citations, last 5 years: 1 616
Works, last 5 years: 284
h-index: 65
Scientists listed: 14
Grants since 2016: 21

Grants received

2022–2025 · research · R21

Identification of Genetic Markers of Susceptibility to Intracellular Bacterial Infection Using the Collaborative Cross Mouse Model

Elke Bergmannleitner · The Geneva Foundation · funded by National Institutes of Health

$171.7k

2022–2024 · research · R21

Identification of Genetic Markers of Susceptibility to Intracellular Bacterial Infection Using the Collaborative Cross Mouse Model

Elke Bergmannleitner · The Geneva Foundation · funded by National Institutes of Health

$215.4k

2021–2023 · research · R21

A platform for genome mining of multidrug-resistant pathogens to develop therapeutic phages using synthetic biology

Yoann Stephane Le Breton · The Geneva Foundation · funded by National Institutes of Health

$103.9kBacteriophages and microbial interactions

2021–2025 · research · R21

A platform for genome mining of multidrug-resistant pathogens to develop therapeutic phages using synthetic biology

Yoann Stephane Le Breton · The Geneva Foundation · funded by National Institutes of Health

$169.1kBacteriophages and microbial interactions

2019–2020 · contract · N01

In Vitro Assessment for Antimicrobial Activity Support (Task Area A)

Rekha Panchal · The Geneva Foundation · funded by National Institutes of Health

$2 500

2019–2020 · contract · N01

TASK B01: COMPREHENSIVE VIRAL SCREENING PANEL

Melissa Beale · The Geneva Foundation · funded by National Institutes of Health

$140.1k

2019–2020 · contract · N01

In Vitro Assessment for Antimicrobial Activity Support (Task Area B)

Melissa Beale · The Geneva Foundation · funded by National Institutes of Health

$2 500

2019–2021 · research · R21

Soman-induced neuropathology in Gottingen minipig: large animal model assessment for MCM

Lucille Lange · The Geneva Foundation · funded by National Institutes of Health

$185.9kPesticide Exposure and Toxicity

2019–2020 · contract · N01

Task A08: In Vitro Bacillus anthracis Lethal Toxin Neutralization Assay for Assessment of 5 Anti-Lethal Factor VHH Clones

Rekha Panchal · The Geneva Foundation · funded by National Institutes of Health

$5 412

2019–2023 · research · R21

Soman-induced neuropathology in Gottingen minipig: large animal model assessment for MCM

Lucille Lange · The Geneva Foundation · funded by National Institutes of Health

$154kPesticide Exposure and Toxicity

2017–2022 · research · R01

Advancing a Candidate Polyclonal Antibody Therapy for Hantavirus Disease

Jay Williams Hooper · The Geneva Foundation · funded by National Institutes of Health

$1MViral Infections and Vectors

2017–2024 · research · R01

Advancing a Candidate Polyclonal Antibody Therapy for Hantavirus Disease

Jay Williams Hooper · The Geneva Foundation · funded by National Institutes of Health

$379.9kViral Infections and Vectors

2017–2020 · research · R21

The carboxylesterase knockout mouse as a model to evaluate the efficacy of delayed medical countermeasures against soman exposure

Lucille Lange · The Geneva Foundation · funded by National Institutes of Health

$149.8kPesticide Exposure and Toxicity

2017–2024 · contract · N01

ANIMAL MODELS OF INFECTIOUS DISEASES SUPPORT

(Contact) · The Geneva Foundation · funded by National Institutes of Health

$3 500

2017–2019 · research · R21

The carboxylesterase knockout mouse as a model to evaluate the efficacy of delayed medical countermeasures against soman exposure

Lucille Lange · The Geneva Foundation · funded by National Institutes of Health

$179.7kPesticide Exposure and Toxicity

2017–2022 · research · R01

Advancing a Candidate Polyclonal Antibody Therapy for Hantavirus Disease

Jay Williams Hooper · The Geneva Foundation · funded by National Institutes of Health

$1.1MViral Infections and Vectors

2017–2022 · research · R01

Advancing a Candidate Polyclonal Antibody Therapy for Hantavirus Disease

Jay Williams Hooper · The Geneva Foundation · funded by National Institutes of Health

$1MViral Infections and Vectors

2017–2022 · research · R01

Advancing a Candidate Polyclonal Antibody Therapy for Hantavirus Disease

Jay Williams Hooper · The Geneva Foundation · funded by National Institutes of Health

$1.1MViral Infections and Vectors

2014–2021 · research · R01

Mammalian and Plant-derived Antibody-based Therapies against Sudan Ebolavirus

John M Dye · The Geneva Foundation · funded by National Institutes of Health

$786.3kViral Infections and Outbreaks Research

2013–2020 · research · R01

Preclinical Assessment of a Multi-Head Electroporation Device for Delivery of Bio

Kathleen A Cashman · The Geneva Foundation · funded by National Institutes of Health

$785kMicrobial Inactivation Methods

2012–2021 · contract · N01

Development of Technologies that Accelerate the Immune Response to Vaccines

Osmer Marjorie · The Geneva Foundation · funded by National Institutes of Health

$168.4k